KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Inventory (2016 - 2025)

Historic Inventory for Staar Surgical (STAA) over the last 16 years, with Q3 2025 value amounting to $55.1 million.

  • Staar Surgical's Inventory rose 3215.31% to $55.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.1 million, marking a year-over-year increase of 3215.31%. This contributed to the annual value of $44.6 million for FY2024, which is 1538.64% up from last year.
  • Staar Surgical's Inventory amounted to $55.1 million in Q3 2025, which was up 3215.31% from $55.2 million recorded in Q2 2025.
  • Staar Surgical's 5-year Inventory high stood at $55.2 million for Q2 2025, and its period low was $16.7 million during Q3 2021.
  • Moreover, its 5-year median value for Inventory was $29.7 million (2023), whereas its average is $32.0 million.
  • Per our database at Business Quant, Staar Surgical's Inventory crashed by 1249.35% in 2021 and then skyrocketed by 6082.56% in 2023.
  • Over the past 5 years, Staar Surgical's Inventory (Quarter) stood at $18.4 million in 2021, then skyrocketed by 40.17% to $25.8 million in 2022, then surged by 49.56% to $38.6 million in 2023, then grew by 15.39% to $44.6 million in 2024, then grew by 23.56% to $55.1 million in 2025.
  • Its Inventory stands at $55.1 million for Q3 2025, versus $55.2 million for Q2 2025 and $50.5 million for Q1 2025.